Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma(twitter.com)
498 points by heydenberk | 231 comments
X post by Moderna co-founder Noubar Afeyan announcing positive Phase 3 results for intismeran autogene, an individualized mRNA neoantigen therapy for melanoma with Keytruda.

